Ansgar Conrad
About Ansgar Conrad
Ansgar Conrad serves as the Vice President of Medical Affairs and Patient Advocacy at Prothena Corporation plc, where he has worked since 2021. He has extensive experience in medical affairs, having held key positions at Actelion, Vifor Pharma, and Stanford Medicine.
Work at Prothena
Ansgar Conrad has been serving as the Vice President of Medical Affairs and Patient Advocacy at Prothena Corporation plc since 2021. In this role, he focuses on enhancing patient care and advancing medical strategies within the organization. His work involves overseeing medical affairs initiatives and fostering relationships with patient advocacy groups. Conrad's position is based in the San Francisco Bay Area, where he contributes to Prothena's mission of developing therapies for neurodegenerative diseases.
Education and Expertise
Ansgar Conrad studied at the University of Tübingen, where he gained foundational knowledge in medical sciences. He furthered his education at San Francisco State University, enhancing his expertise in medical affairs. His academic background supports his extensive experience in the pharmaceutical industry, particularly in medical affairs and patient advocacy.
Background
Before joining Prothena, Ansgar Conrad held significant positions in various organizations. He worked at Actelion as the Director of Medical Affairs from 2007 to 2015, where he managed medical strategies and initiatives. Following that, he served as the Executive Director of Medical Affairs at Vifor Pharma from 2015 to 2021. His early career included a role as a researcher at Stanford Medicine from 2003 to 2007, where he contributed to medical research projects.
Achievements
Ansgar Conrad has been involved in key initiatives aimed at improving patient care. Notably, he played a role in Prothena's partnership with ASPIRE, a collaborative effort focused on enhancing diagnosis and care for patients with amyloidosis. This partnership reflects his commitment to advancing medical practices and advocating for patient needs in the healthcare sector.